Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $1.3 million.

  • Artiva Biotherapeutics' Treasury Shares changed N/A to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $506845.0 for FY2024, which is 215124.37% up from last year.
  • As of Q3 2025, Artiva Biotherapeutics' Treasury Shares stood at $1.3 million.
  • In the past 5 years, Artiva Biotherapeutics' Treasury Shares registered a high of $1.5 million during Q1 2025, and its lowest value of $22514.0 during Q4 2023.
  • Its 3-year average for Treasury Shares is $957810.2, with a median of $1.3 million in 2025.
  • Examining YoY changes over the last 5 years, Artiva Biotherapeutics' Treasury Shares showed a top increase of 215124.37% in 2024 and a maximum decrease of 215124.37% in 2024.
  • Artiva Biotherapeutics' Treasury Shares (Quarter) stood at $22514.0 in 2023, then soared by 2151.24% to $506845.0 in 2024, then soared by 165.07% to $1.3 million in 2025.
  • Its Treasury Shares was $1.3 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.5 million in Q1 2025.